2023 Form 5500 filing — Envision Pharma, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241015160318NAL0058605042001) for Envision Pharma, Inc. 401(K) Plan, reported by Envision Pharma, Inc. under EIN 06-1633253 and plan number 001. It reports 967 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241015160318NAL0058605042001
Filing year
2023
Form type
2
Plan sponsor
Envision Pharma, Inc.
EIN
06-1633253
Plan number
001
Location
Fairfield, CT
Participants
967
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$77,496,149
Total liabilities (EOY)
$33,210
Net assets (EOY)
$77,462,939
Employer contributions
$3,236,864
Participant contributions
$8,034,867
Total income / additions
$24,707,475
Benefits paid
$6,221,707
Administrative expenses
$223,294
Total expenses
$6,457,747
Net increase / (decrease)
$18,249,728
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Mma Securities, LLCINVESTMENT/FINANCIAL ADVI$128,920$0
Adp, Inc.RECORD KEEPER$94,299$0
Td Ameritrade, Inc.SECURITES BROKER$75$0
Adp Broker-DealerRECORD KEEPER$0$0

Related Form 5500 pages